Bio
Profile
Experience
Allen Gledhill LLP, Singapore (2013)
The Innovation Type Pharmaceutical Company Certification Committee, Ministry of Health and Welfare (MOHW) (2012)
Kim & Chang (2007-Present)
Member, ROKAF Aerospace Law Research Committee (2004-2007)
Judge Advocate, Republic of Korea Air Force (2004-2007)
Representative Mattersshow
Major Legal Consultation and Advice in Pharmaceutical, Medical Devices, Food and Medical Service Sectors:
- Advised clients during Korea Fair Trade Commission’s 1st, 2nd, and 3rd rounds of investigations into the pharmaceutical industry for unfair trade practices.
- Advised clients during Korea Fair Trade Commission’s patent abuse investigations.
- Advised clients during illegal rebate investigations under the dual punishment system.
- Advised on establishing a global compliance standard of practice for multinational pharmaceutical companies.
- Advised on new drug listings.
- Advised on regulatory matters in connection to M&As.
- Advised on execution of licensing and distribution agreements.
- Advised on termination of co-promotional and distribution agreements.
- Advised clients on responses and defenses against administrative measures for violations of the Pharmaceutical Affairs Law and Medical Device Act.
- Advised on side effects in connection to clinical trials.
- Advised on the establishment of medical institutions.
Representative Activitiesshow
Awards
- Awarded Korea Air Force Chief of Staff Citation/Decoration for Outstanding Legal Research (2006)
- Awarded Minister of Commerce, Industry and Energy Citation/Decoration for Outstanding Legal Research (2005)
- Awarded Korea Air Force Chief of Staff Citation/Decoration for Outstanding Legal Service (2004)
Publications/Activities
- Review on Directors’ Responsibilities for Corporate Compliance - Practical Issues and Analysis on Current Judicial Precedent, BFL Vol.113 (Seoul National University Center for Financial Law, 2022)
- Lexology Getting the Deal Through - ESG & Impact Investing 2022: Korea Chapter (Co-author, Law Business Research, 2021)
- Study on Legitimacy of Regulation on Pharmaceutical Company's Health Campaign (The Journal of Regulation Studies Vol.22, No.1, 2013.6.)
- Study on Institutional Review Board’s Roles in Regulating Illegal Rebate (Human Right and Justice Vol.434, 2013.6.)
- Expanded Access Program under Pharmaceutical Affairs Act (Korean Journal of Medicine and Law Vol.21, No.1, 2013.6.)
- Review of Medical Necessity as Requirement for Claim of Medical Service Fees Arising from “Arbitrary Uninsured Medical Benefits” (The Justice Vol.135, 2013.4.)
- Necessities and Required Measures to Amend the KPMA's Promotion Code (Korean Journal of Medical Ethics Vol.16, No.1, 2013.4.)
- Overseas Legal Systems to Enhance Transparency in Healthcare Industries and Those Implications in South Korea - Focusing the United States' Sunshine Act and Japanese Transparency Guideline (Lawyers Association Journal Vol.62, No.4, 2013.4.)
- Use of Corporate Integrity Agreement in United States and Its Implications in South Korea - Focusing on Health Care Industry (InHa Law Review Vol.16, No.1, 2013.3.)
- The Patient Protection and Affordable Care Act and the Principle of Private Autonomy in Medicine (Hanyang Law Journal Vol.30, No.1, 2013.3.)
- Study on Discussion for Deregulation of Direct-to-Consumer Advertising of Ethical Drugs - Focusing on Cases of the United States, Canada and the European Union (Yonsei Law Review Vol.23, No.1, 2013.3.)
- Legal Liability Arising from Off-Label Use Promotion of Drugs - Focusing on Critical Analysis of Introduction of the United States Control System such as Qui Tam Action (Ewha Law Review Vol.17, No.3, 2013.3.)
- Review of Legal and Political Legitimacy of Automatic Appointment - Regime of Medical Service Providers under National Health Insurance System (Journal of Law and Politics Research Vol.13, No.1, 2013.3.)
- Critical Consideration on Korean Supreme Court’s Criteria for Separating Clinical Trials from Individual Medical Practices (Seoul Law Journal Vol.54, No.1, 2013.3.)
- Legal Definition of "Conducting the Business of Another Person" in the Commercial Bribery Provision Applied to Physicians (Korea Law Review Vol.68, 2013.3.)
- Legal Issues Relating to Group Purchasing Organizations in Medical Industry (Seoul Law Review Vol.20, No.3, 2013.2.)
- The Review of Legal Problems Arising from Financial Supports for Investigators Initiated Trials (Korean Journal of Medicine and Law Vol.20, No.2, 2012.12.)
- A Study of the Current Status and Future Development of the Regime of Security Interests in Aircraft (Master's Dissertation, Seoul National University, 2007)
- An Analysis on the Legal Solution of Dispute caused by the Use of GMO Product (BIOSAFETY JOURNAL Vol.6, No.1, 2005)
- A Legal Review of the Military Use and Control of Civil Satellite (AEROSPACE LAW JOURNAL Vol.20, No.2, 2005)
Education
University of London, LSHTM (M.S.P.H., 2018)
School of Law, Seoul National University (S.J.D., Candidate, 2015)
Cornell Law School (LL.M., 2013)
The Wharton School Executive Program: Making an Impact as a Global Health Leader (2013)
Graduate School of Law, Seoul National University (LL.M., 2007)
Judicial Research and Training Institute of the Supreme Court of Korea (2004)
College of Law, Seoul National University (LL.B., 2002)
Qualifications
Admitted to bar, Korea, 2004; New York, 2015
Languages
Korean and English
Insights
-
News
[The Korean Economic Daily] Kim & Chang Compliance Group: Supporting Domestic and Global Companies in Regulatory Disputes; Providing Comprehensive Consulting Services Encompassing Areas Including AI and ESG
2024.04.24 -
Newsletters
Anonymous Apps and Whistleblowing
2024.02.15 -
Newsletters
Directors’ Duty to Monitor and Supervise Company
2024.02.15 -
Newsletters
Amendments to General Investigation Rules
2024.02.15 -
Newsletters
Police Investigations of Overseas Companies
2024.02.15 -
Newsletters
2024 Compliance Outlook Newsletter
2024.02.15